SAN DIEGO, Aug. 5, 2014 /PRNewswire/ -- Volcano Corporation (Nasdaq: VOLC), a leading company focused on improving patient and economic outcomes on a global basis by developing and delivering innovative minimally invasive coronary and peripheral visualization, physiology diagnostics and therapies, said today that it will be participating in the Canaccord Genuity Growth Conference on Wednesday, August 13.
The presentation by Scott Huennekens, president and chief executive officer, will begin at 1:30 p.m., Eastern Daylight Time (10:30 a.m., Pacific Daylight Time). The presentation will be available through the company's website at http://www.wsw.com/webcast/canaccord14/ and via the company's website at www.volcanocorp.com.
About Volcano Corporation
Through its multi-modality platform, Volcano Corporation is the global leader in intravascular imaging for coronary and peripheral applications, and physiology. The company also offers a suite of peripheral therapeutic devices. The company's broad range of technologies makes imaging and therapy simpler, more informative and less invasive and offers physicians and their patients around the world with industry-leading tools that aid diagnosis and guide and provide therapy. Founded in cardiovascular care and expanding into other specialties, Volcano is focused on improving patient and economic outcomes. For more information, visit the company's website at www.volcanocorp.com.
SOURCE Volcano Corporation